This inventor holds 1 USPTO granted patent. Top assignee: Sankyo Company, Limited. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Ayako Hara: Innovator in Therapeutic Research
Introduction
Ayako Hara is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of therapeutic agents for viral infections and tumors. Her innovative work has led to the development of valuable patents that enhance our understanding of disease mechanisms.
Latest Patents
Ayako Hara holds a patent for "2', 5′-oligoadenylate phosphodiesterase - Polypeptides having 2',5′-oligoadenylate phosphodiesterase activity, antibodies against the polypeptides, polynucleotides coding for the polypeptides, recombinant plasmid DNAs into which the polynucleotides have been inserted, host cells transformed by the recombinant plasmid DNAs, processes for screening for 2′,5′-oligoadenylate phosphodiesterase activity inhibitor substances, and processes for screening for 2′,5′-oligoadenylate phosphodiesterase expression regulation inhibitor substances." This patent is crucial for the search for therapeutic agents targeting viral infections and tumors. She has 1 patent to her name.
Career Highlights
Ayako Hara is associated with Sankyo Company, Limited, where she has been instrumental in advancing research in her field. Her work has garnered attention for its potential applications in medicine and therapeutic development.
Collaborations
Ayako has collaborated with notable colleagues, including Yasuteru Iijima and Kaori Nakahara. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Ayako Hara's contributions to therapeutic research through her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in medical treatments.